Sign in

ESMO - European Society for Medical Oncology

@myesmo.bsky.social
716 followers 149 following 760 posts

The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.

PostsRepliesMedia
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 08/10/2026
👉 Registration is open for ESMO Sarcoma and Rare Cancers Congress 2027 (4-6 March, Lugano, Switzerland). ⏰ Register by 7 January for the best rates and join the global community advancing care for rare solid tumours. 🔗 ow.ly/Hkbc50ZUOpL #ESMORareCancers27 #esmomeetings
011
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 07/10/2026
👉 New for ESMO members! The ESMO Handbook of Cancer Prevention provides you with up-to-date evidence and global standards for primary, secondary and tertiary prevention. 🔗 Download the book now! ow.ly/Gmfu50ZUwb3 #ESMOBooks
012
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 07/10/2026
🤖 #ESMOAI26 Real-world data is reshaping cancer care. Discover how real-world evidence is advancing research, informing treatment decisions, and driving innovation in oncology during our Educational session. ⏰ Register by 28 October and save! 🔗 ow.ly/4xxv50ZTTrr #esmomeetings
022
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 06/10/2026
👉 Register now for the ESMO Immuno-Oncology & Advanced Therapies Congress 2026 🔗 ow.ly/9mhv50ZUUnS 📍 London, UK 📅 14-16 December 2026 ⏳ Early registration closes on 14 October #ESMOImmuno26 #ESMOMeetings
011
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 06/10/2026
👉 In this #ESMODeepDive, we explore the evolving treatment landscape in relapsed #OvarianCancer, from changing concepts of platinum-sensitive relapse to the role of antibody-drug conjugates and therapeutic sequencing 🔗ESMO members: ow.ly/BpFL50ZTT4J #ESMOOnAir
000
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 05/10/2026
🤖 #ESMOAI26 : The wait is over! Abstract authors and titles are now online! What’s next for AI & Digital Oncology? Explore the science, technology, and real-world questions shaping the field at our upcoming event. ⏰ Register by 28 October and save! 🔗 ow.ly/7nQv50ZTNQX #esmomeetings
032
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 05/10/2026
🌏 Global collaboration drives progress in GU oncology. Join the conversation at #ESMOGUAsia27 and share your latest research with experts from across Asia and the world. 📅 Abstract deadline: 13 October 👉 ow.ly/foEF50ZTNV2 #ESMOMeetings #GUOncology
022
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 02/10/2026
The #ESMOAmbassadors represent expertise across tumour types and oncology disciplines. Explore their profiles and discover which Ambassadors to follow during #ESMO26. 🔗 ow.ly/cyUC50ZOEjF
010
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 01/10/2026
@gerryhanna.bsky.social @drjnaidoo.bsky.social @solangepeters.bsky.social @arselaprelaj.bsky.social @bensolomon1.bsky.social
010
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 01/10/2026
📣 Abstract submission for #ELCC27 is now open. Share your research with a focused, multidisciplinary thoracic oncology community. Gain valuable feedback, increase the visibility of your work and start new collaborations. 🔗 Submit now - ow.ly/Jrtf50ZTpbk
143
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 01/10/2026
👉 #ESMOBreast27: Are you ready to have a global impact in breast cancer research? Submit your abstract and be part of the change! Your contribution will be key to driving progress and advancing patient care worldwide ⏰ Deadline 2 February 2027 🔗 ow.ly/ozrC50ZT3E8 #esmomeetings
001
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 01/10/2026
👉 The abstract titles for ESMO Asia 2026 are now online. Explore the research to be presented and register by 4 November to save on your registration. Join the Asian and global oncology community in Singapore, 4-6 December. 🔗 ow.ly/EBX950ZSZUo #ESMOAsia26 #esmomeetings
011
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 30/09/2026
ESMO Frameworks help provide the standards, guidance and shared language needed to support informed decision-making across #CancerCare. Discover why frameworks matter and the value they bring to the #OncologyCommunity. 🧷https://www.esmo.org/frameworks-and-tools ​ @fandremd.bsky.social
000
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 29/09/2026
👉 In this #ESMOGuidelines webinar, we explore the ESMO Clinical Practice Guidelines for early stage and locally advanced #NSCLC, applying key recommendations to a real-world case in multidisciplinary #LungCancer care 🔗 ow.ly/2Q5R50ZRjP7
010
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 28/09/2026
📣 #ESMOBreast27: The wait is over – the programme is now online! And it's packed with expert perspectives and opportunities to connect with the global breast cancer community. Start identifying the sessions most relevant to your work and plan your time in Milan 🔗 ow.ly/vCVG50ZRjLz
000
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 24/09/2026
👉 Updated ESMO #ClinicalPracticeGuideline on cervical cancer: updated recommendations reflect major advances in surgical de-escalation, immunotherapy and emerging treatments 🔗 ow.ly/LgJK50ZQrWC #ESMOGuidelines
001
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 24/09/2026
👉 ESMO Asia 2026, Singapore, 4-6 December: where science meets purpose. Join oncology leaders from across Asia for education, science and multidisciplinary exchange - rare cancers and supportive care included. Register by 4 November and save. 🔗 ow.ly/uuyK50ZQrjp #ESMOAsia26 #esmomeetings
011
Reposted by ESMO - European Society for Medical Oncology
Philippe Aftimos, MD @aftimosp.bsky.social · 22/09/2026
With #ESMO26 in Madrid around the corner, the LBAs list os now available online and in the program! #ESMOAmbassadors
011
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 23/09/2026
🤖 #ESMOAI26 What role will multimodal foundation models and AI agents play in oncology? Explore the latest developments shaping research and clinical practice with C. Bunne during her keynote lecture. ⏰ Register by 28 October and save! 🔗 ow.ly/Mq6F50ZPyHT #esmomeetings
022
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 22/09/2026
📣 #ESMO26: The late-breaking abstract lineup is taking shape! Authors & titles are online, and most of the submissions are already there. 30K+ delegates already registered from around the world, so this means new data, new insights and new opportunities to connect. 🔗 ow.ly/6Res50ZQ82a
053
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 22/09/2026
📢 Your research could help shape the future of GU cancer care in Asia. Join the scientific discussion at #ESMOGUAsia27 and share your latest findings. 📅 Abstract deadline: 13 October 👉 Submit your abstract: ow.ly/MwST50ZPFnS #ESMOMeetings #GUOncology
001
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 18/09/2026
👉 Dr. Sandra D'Angelo, New York, USA, is looking for research that helps crack the code of immune resistance in sarcoma. Could your work be the next step forward for patients? ⏰ Submit your abstract by 24 November. #ESMORareCancers27 #esmomeetings 🔗 ow.ly/aQXr50ZMrv5
001
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 18/09/2026
ESMO is pleased to announce the #ESMOAmbassadors for #ESMO26. They will share scientific highlights, expert perspectives and insights on the latest research presented at #ESMO26 across tumour types and disciplines. 🔗Discover the Ambassadors: ow.ly/BQ3i50ZOkEv
052
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 17/09/2026
As oncology continues to evolve, innovation alone is not enough. Evidence-based standards, classifications and frameworks are essential to support consistent implementation in #ClinicalPractice across health systems. ​🔗https://ow.ly/R5Bl50ZOzCM ​ @fandremd.bsky.social
031
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 16/09/2026
👉 Could your research be part of #ESMOImmuno26? Abstract submission is open until 22 Sept 2026 for research in immuno-oncology, biomarkers, cell therapies, cancer vaccines and advanced therapies. 🔗 Submit today: ow.ly/3EUg50ZMAts #ESMOMeetings
030
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 15/09/2026
🤖 #ESMOAI26 Watch Prof. Jakob Kather while he shares his vision and invites you to attend the second edition of the ESMO AI & Digital Oncology Congress 2026. Register by 28 October and save. 🔗 ow.ly/1WMs50ZKhH3 #esmomeetings
042
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 14/09/2026
👉 #MAP2026 sessions (where speaker permission is granted) are now online for registered delegates & ESMO members via #OncologyPRO. 🔬 Watch on demand & keep up with the latest in #PrecisionOncology! 🔗 ow.ly/u4PN50ZNcr9
011
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 14/09/2026
Discover how #pathology helps shape treatment decisions in #oncology. Join David Rimm, Heike Grabsch, Myrto Moutafi and Maximilian Kloft at the #YO4YO HowTo Virtual Session. 📅 14 Sept 2026, 15:00-16:00 CEST #ESMOYOC 🔗 ow.ly/uIlV50ZATTP
000
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 14/09/2026
📣 #ESMO26: 4 Keynotes. 1 stage. The next frontier of oncology – CNS disease, AI-driven prediction, radioligand therapy & the role of ageing in cancer. ⏰ Last chance to register at preferential fees - late registration deadline: 16 September 2026 🔗 ow.ly/xh2Y50ZLVMY #esmomeetings
020
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 11/09/2026
#MAP2026: The #NervousSystem influences tumour behaviour. Leanne Li discusses emerging evidence on #NeuralSignalling and how neural and immune pathway interactions could shape #TumourProgression and treatment response. #ESMODailyReporter: ow.ly/L9sV50ZMy12
010
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 11/09/2026
#MAP2026: Latest #ClinicalResearch in #TNBC identifies potential novel drivers of chromosome instability linked to immune evasion and #biomarkers of early recurrence post #chemotherapy, expanding knowledge of this aggressive cancer. #ESMODailyReporter:https://ow.ly/lCm550ZMxtZ
001
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 10/09/2026
ESMO's new Clinical Trials Funding initiative supports independent academic pragmatic clinical trials to improve #CancerCare and patient outcomes. Open to academic institutions, hospitals, research groups. Application deadline: 1 November 2026 ow.ly/v8n850ZLX3q
012
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 10/09/2026
#MAP2026: Novel tests based on epitranscriptomics and detection of cell-free CTCF-DNA fragments could help #LiquidBiopsy fulfil its promise of #EarlyDetection of cancer, with early results showing high sensitivity and specificity. #ESMODailyReporter: ow.ly/CrSC50ZLWgI
000
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 10/09/2026
#MAP2026: #SpatialTranscriptomic analyses identified actionable cellular and molecular #biomarkers, including a 9-gene cell surface signature as potential therapeutic targets in #osteosarcoma, as discussed by Emanuela Palmerini. #ESMODailyReporter: ow.ly/2GAg50ZLTAF
000
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 10/09/2026
👏 Congratulations to the #ESMOMeritAward recipients at #MAP2026. These young researchers are recognised for the scientific merit of their abstracts. 🔗 ow.ly/5XXJ50ZLf2y #PrecisionOncology
000
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 10/09/2026
🙌 Welcome to #MAP2026 The #PrecisionOncology community is coming together in London for two days of science, exchange and collaboration. From molecular diagnostics to clinical translation, join the conversations shaping the future of cancer care. 🔗 ow.ly/xUUk50ZJe1g
000
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 09/09/2026
📣 #ESMO26: Join Prof. James Larkin, Scientific Committee Co-Chair, to exchange perspectives, debate emerging evidence, and discuss the future of cancer prevention, diagnosis, and treatment. ⏰ Late registration deadline: 16 September 2026 🔗 ow.ly/q9GM50ZJcZh #esmomeetings
034
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 08/09/2026
👉 In this #ESMOOnAir webinar, we focus on optimising antibody-drug conjugate safety, from prevention and risk mitigation to the recognition and management of ADC-related ILD and ocular toxicity 🔗 ow.ly/77er50ZIEBB
000
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 08/09/2026
🤖 #ESMOAI26 How can maths and AI drive breakthrough discoveries in cancer research? Explore innovative computational approaches that are transforming how we understand and tackle cancer. ⏰ Register by 9 September for the best fees. 🔗 ow.ly/xWzr50ZI8jK #esmomeetings
001
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 07/09/2026
Abstracts are online for #MAP2026! 📍 London | 10–11 Sept 👉 From molecular insights to clinical impact, discover the research driving progress in #PrecisionOncology. Join leading experts in London for two days of science, innovation and collaboration. 🔗 ow.ly/9h5850ZI8va
032
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 07/09/2026
How does biology drive treatment decisions in oncology? Join the #YO4YO HowTo Virtual Session to explore the role of pathology in clinical practice with David Rimm, Heike Grabsch, Myrto Moutafi and Maximilian Kloft. #ESMOYOC 📅 14 Sept 2026, 15:00-16:00 CEST 🔗 ow.ly/uIlV50ZATTP
022
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 07/09/2026
🌍 Radiotherapy is a key component of multidisciplinary GU cancer care. This #WorldRTDay, join the conversation at #ESMOGUAsia27. 📅 Abstract submission deadline: 13 October 👉 ow.ly/URfk50ZJg3a #WRAD #ESMOMeetings
023
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 04/09/2026
👏 Leonardo Brunetti has been selected as the recipient of the inaugural ESMO #ArtificialIntelligence (#AI) Fellowship. Supporting AI-driven solutions that bridge data science and patient care. 🔗 ow.ly/F2Sf50ZIxXR #ESMOFellowships
000
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 04/09/2026
👏 Wiebke Solass has been selected as the recipient of the ESMO Digital and Computational Pathology Fellowship. This fellowship supports physicians seeking to advance their knowledge and skills in this rapidly evolving field. 🔗 ow.ly/l6gZ50ZIy09 #ESMOFellowships
000
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 03/09/2026
👏 We are pleased to announce Mihaela Aldea as the 2026 recipient of the ESMO José Baselga Fellowship for Clinician Scientists. This fellowship provides the resources & #mentorship for #ClinicianScientists. Gustave Roussy 🏥 🔗 ow.ly/oCic50ZIxFo #ESMOFellowships
011
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 03/09/2026
🤖 #ESMOAI26 Watch Prof. Jakob Kather while he shares how the programme was developed and what you can expect from it. ⏰ Register by 9 September for the best fees. 🔗 ow.ly/aoNo50ZF9Iw #esmomeetings
033
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 02/09/2026
⏳ #MAP2026 starts soon. Join leading clinicians and scientists in London, 10-11 Sept, for focused discussions on the latest advances in #PrecisionOncology. Regular registration is open. Secure your place today. 🔗 ow.ly/xFAn50ZF2H5
000
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 02/09/2026
🌎 28 recipients. One shared goal: advancing #CancerCare. 🌟 The ESMO Leadership and Career Development Award provides international research opportunities, leadership training and protected project time. 🔗 ow.ly/nuYG50ZHJe0 #ESMOFellowships
000
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 01/09/2026
ESMO has announced the recipients of the 2026 ESMO Society Awards, recognising four #OncologyProfessionals whose contributions have advanced #CancerResearch and #CancerCare. 🔗 ow.ly/UJ9750ZHiof
000
ESMO - European Society for Medical Oncology @myesmo.bsky.social · 01/09/2026
👉 In this #ESMODeepDive, we address the challenge of first-line therapy for HRD-negative advanced #OvarianCancer, from HRD testing limitations to PARP inhibitor maintenance and emerging antibody-drug conjugates. ESMO members: ow.ly/3HNN50ZF3Gm #ESMOOnAir
000